Placeholder Banner

BIO Submits Comments to the Office of Science Technology and Policy (OSTP) on the Bioeconomy

October 22, 2019

The Biotechnology Innovation Organization (BIO) has submitted comments to the Office of Science Technology and Policy (OSTP) on the bioeconomy, explaining the critical role America’s biotechnology industry plays in feeding, fueling, and healing the world. The comments were recently highlighted by Tom DiLenge, president of BIO’s Advocacy, Law & Public Policy Division, during The White House Summit on America’s Bioeconomy, which included leaders from industry, academia, and the government.

“It’s a remarkable time for the biotechnology industry in America. Our world-class scientists, brilliant researchers, and savvy entrepreneurs are making an enormous difference in improving the health of our loved ones and our planet,” DiLenge noted. “Yet while our progress has been amazing, the continued success and leadership of the American biotech industry is not guaranteed. We cannot abandon the policies that have made our bioeconomy the strongest and most dynamic in the world, and we must work to update our policies to meet the challenges posed by the next wave of biotechnological innovations.”

Read the full comments via the link below.

Download Full Comments Below
BIO's White House Bioeconomy Submission
Discover More
We are writing regarding the proposed 2018 Renewable Volume Obligation under the RFS. Rather than support continued growth in the lowest carbon types of biofuels under the statue, your proposal reduces the blending target for cellulosic biofuels and…
As you finalize the proposed rules under the Renewable Fuel Standard, we respectfully urge you to not reduce the biofuels volume requirements. The RFS program has helped the environment, our economy, and has increased our confidence in renewable…
The Biotechnology Innovation Organization (BIO), along with the 27 members of the Council of State Bioscience Associations (CSBA), urge Congress to support the Advancing Emergency Preparedness Through One Health Act and advance legislation…